Cochlear ups investment in sleep device

Hearing implant group Cochlear has increased its investment in a start-up business developing a device to combat obstructive sleep apnea. Apnea, a market dominated by Cochlear’s Australian rival ResMed, has attracted a number of competing devices with healthcare company Nyxoah pursuing a novel approach. The company’s device (pictured) stimulates the tongue nerve during sleep, triggering…